DACARBAZINE - search results

dacarbazine medec 200 mg, powder for solution for injection / infusion

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - dacarbazine - powder for solution for injection/infusion - dacarbazine 10 mg/ml - antineoplastic agents

Australia - English - Department of Health (Therapeutic Goods Administration)

dbl dacarbazine

hospira australia pty ltd - dacarbazine -

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira dacarbazine for injection 600 mg/ vial

hospira australia pty ltd - dacarbazine, quantity: 600 mg - injection, powder for - excipient ingredients: citric acid monohydrate; mannitol; sodium hydroxide - dacarbazine is indicated for the treatment of patients with metastatic malignant melanoma. dacarbazine is used as part of combination chemotherapy for the treatment of advanced hodgkin's disease, advanced adult soft tissue sarcomas (except mesothelioma and kaposi sarcoma). dacarbazine has been shown, when used in combination with other cytotoxic agents, to be of use in the treatment of other malignant diseases including carcinoma of the colon, ovary, breast, lung, testicular teratoma, and solid tumours in children.

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira dacarbazine for injection bp, 200 mg vial

hospira australia pty ltd - dacarbazine, quantity: 200 mg - injection, powder for - excipient ingredients: citric acid monohydrate; mannitol; sodium hydroxide - dacarbazine is indicated for the treatment of patients with metastatic malignant melanoma. dacarbazine is used as part of combination chemotherapy for the treatment of advanced hodgkin's disease, advanced adult soft tissue sarcomas (except mesothelioma and kaposi sarcoma). dacarbazine has been shown, when used in combination with other cytotoxic agents, to be of use in the treatment of other malignant diseases including carcinoma of the colon, ovary, breast, lung, testicular teratoma, and solid tumours in children.

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira dacarbazine for injection usp, 200 mg vial

hospira australia pty ltd - dacarbazine, quantity: 200 mg - injection, powder for - excipient ingredients: citric acid monohydrate; mannitol; citric acid; sodium hydroxide - dacarbazine for injection is indicated in the treatment of metastic malignant melanoma. in addition, its also indicated for hodgkin's disease as a second line therapy when used in combination with other effective agents.